NetMeds acquires JustDoc for just under a million

NEW DELHI: Online pharmacy Net-Meds has acquired telemedicine portal JustDoc in a cash-and-stock deal, the second acquisition by the Chennai-based company, which had acquired hyperlocal drugs delivery startup Pluss last year.

NetMeds acquires JustDoc for just under a million While the terms of the transaction were not disclosed, Netmeds is believed to have paid a little under $1 million to acquire three-year-old JustDoc, which counts former Infosys senior executive TV Mohandas Pai, InMobi cofounder Mohit Saxena, TaxiForSure cofounder Raghunandan G as its angel investors and Singapore Angel Network and Tracxn Labs among its list of backers. All the investors of JustDoc, who had invested an undisclosed amount in the Bengaluru-based venture, are believed to be exiting the startup, post the closure of the deal.

“We were looking to add diagnostic services, given that our aim is to provide a more holistic health platform to our consumers, particularly those dealing with chronic health issues… Getting into diagnostics and telemedicine was a critical part,” Pradeep Dadha, chief executive of NetMeds, told ET.

This is the second acquisition by NetMeds, which competes with the likes of Sequoia Capital-backed 1mg. The latest buyout, according to Dadha, has been funded from the proceeds of the company’s last equity financing round, which was announced earlier this month.

NetMeds had raised $35 million in its Series-C round, which was led by Singapore-based Daun Penh Cambodia Group, and also saw participation from its existing set of investors, a list that includes Sistema Asia Fund, the venture capital arm of Russian conglomerate Sistema JSFC and Tanncam Investment, a Cambodian investment holding company, according to reports.

  • Related Posts

    Cancer cure must not be hostage to Big Pharma

    In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Pune:- A woman, 34, dia­gnosed with poly­cystic ovary syn­drome, or PCOS, as a teen­ager, saw her first nat­ural men­strual cycle in Feb­ru­ary—six months after start­ing Moun­jaro for weight man­age­ment. This…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients